Please use this identifier to cite or link to this item:
Title: Endovascular Treatment of Intracranial Aneurysms Using the Novel Low Profile Visualized Intraluminal Support EVO Stent: Multicenter Early Feasibility Experience.
Austin Authors: Foo, Michelle ;Maingard, Julian;Hall, Jonathan;Ren, Yifan;Mitreski, Goran;Slater, Lee-Anne;Chandra, Ronil;Chong, Winston;Jhamb, Ashu;Russell, Jeremy H ;Kok, Hong Kuan;Brooks, Duncan Mark ;Asadi, Hamed 
Affiliation: Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia
Interventional Radiology Service, Department of Radiology, Northern Health, Epping, VIC, Australia
Faculty of Medicine and Health Sciences, Macquarie University, Macquarie Park, NSW, Australia
Interventional Neuroradiology Service
Interventional Neuroradiology Service, Department of Radiology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia
Interventional Neuroradiology Service, Department of Radiology, Monash Health, Clayton, VIC, Australia
Department of Imaging, Monash University, Clayton, VIC, Australia
Neurosurgery Department, Austin Health, Heidelberg, VIC, Australia
School of Medicine, Deakin University, Waurn Ponds, VIC, Australia
Florey Institute of Neurosciences and Mental Health, The University of Melbourne, Parkville, VIC, Australia
Issue Date: Jul-2021
Date: 2021-06-18
Publication information: Neurointervention 2021; 16(2): 122-131
Abstract: Low-profile, self-expandable stents have broadened therapeutic options available for definitive treatment of intracranial aneurysms. The novel Low-Profile Visualized Intraluminal Support (LVIS) EVO stent extends upon the success of its predecessor, the LVIS Jr stent, aiming to enable higher visibility and greater opening ability within a self-expandable and fully retrievable microstent system. In this study, we aim to report the early safety and feasibility experience with the LVIS EVO stent. A multicenter, retrospective, observational study was conducted on patients who had intracranial aneurysms treated with the LVIS EVO stent across 3 Australian neurovascular centers between February 2020 and September 2020. Short-term technical and clinical outcomes were evaluated. A total of 22 LVIS EVO stents were successfully implanted to treat 15 aneurysms (3 ruptured, 12 unruptured) in 15 patients. Aneurysms ranged from 2 mm to 35 mm in dome height. The LVIS EVO stent was used for stent-assisted coiling in 11 patients and flow diversion in 4 patients. There were no device-related procedural complications. There were 2 cases of peri-procedural symptomatic thromboembolic complications and no procedure-related mortality. At early radiological follow up, 10 patients had complete occlusion, 4 patients had small neck remnants, and 1 patient who was managed with flow diversion had a residual aneurysm. Early experience with the LVIS EVO stent demonstrated safety and feasibility for stent-assisted coiling as well as flow diversion for intracranial aneurysms. In this heterogeneous cohort, including ruptured, complex, and large aneurysms, all cases were technically successful.
DOI: 10.5469/neuroint.2021.00199
Journal: Neurointervention
PubMed URL: 34139794
ISSN: 2093-9043
Type: Journal Article
Subjects: Endovascular techniques
Interventional radiology instrumentation
Intracranial aneurysm
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Apr 17, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.